Correction to: Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity

類似資料

• Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity
  著者:: Dan Aravot, 等
  出版事項: (2019-01-01)
• Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity
  著者:: Dan, Aravot, 等
  出版事項: (2019)
• Stereotactic body radiotherapy for central lung tumors, yes we can!
  著者:: Korzets ceder, Yasmin, 等
  出版事項: (2018)
• Intensity‐modulated radiotherapy is a safe and effective treatment for localized malignant pleural mesothelioma
  著者:: Simon, Michael, 等
  出版事項: (2018)
• Two are better than one on progression through MET mechanism for EGFR+ NSCLC patients
  著者:: Kian, Waleed, 等
  出版事項: (2018)